Chylothorax after off-pump coronary artery bypass graft surgery: Management strategy

Hemant Digambar Waikar1, Peter Kamalaneson2, Mohamad Saleh Mohamad Zamri2

  • 1Department of Cardiothoracic Anaesthesia, Nawaloka Hospitals, Colombo, Sri Lanka.

Insights

Chylothorax, a rare cardiac surgery complication, can be managed effectively. Treatment involves thoracic duct injury management, nutritional support, octreotide, and pleurodesis for successful outcomes.

Area of Science:

  • Cardiothoracic Surgery
  • Thoracic Surgery
  • Surgical Complications

Background:

  • Chylothorax is a rare but serious complication following cardiac surgery.
  • Thoracic duct injury during left internal thoracic artery harvesting for coronary artery bypass graft (CABG) is a common cause.
  • This condition is associated with significant morbidity and mortality.

Observation:

  • A case of chylothorax occurred after off-pump coronary artery bypass graft (CABG) surgery.
  • The patient presented with symptoms indicative of chylothorax post-operation.

Findings:

  • Successful management was achieved through a multi-modal approach.
  • Treatment included thoracostomy tube drainage, cessation of oral intake, and total parenteral nutrition.
  • Administration of subcutaneous octreotide and chemical pleurodesis were key components of the treatment strategy.

Implications:

  • This case highlights a successful conservative management strategy for post-cardiac surgery chylothorax.
  • The described treatment regimen offers a viable option for managing this rare complication.
  • Effective management can mitigate the morbidity and mortality associated with chylothorax.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
492
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
344
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
283
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
391
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
703